Search Results - "Silvis, J M"

Refine Results
  1. 1
  2. 2

    Extracellular Vesicle cystatin c is associated with unstable angina in troponin negative patients with acute chest pain by Dekker, Mirthe, Waissi, Farahnaz, van Bennekom, Joelle, Silvis, Max J M, Timmerman, Nathalie, Schoneveld, Arjan H, Grobbee, Diederick E, de Winter, Robbert J, Mosterd, Arend, Timmers, Leo, de Kleijn, Dominique P V

    Published in PloS one (05-08-2020)
    “…Despite the use of high-sensitive cardiac troponin there remains a group of high-sensitive cardiac troponin negative patients with unstable angina with a…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5
  6. 6

    Targeting residual inflammatory risk in coronary disease: to catch a monkey by its tail by Fiolet, A. T. L., Opstal, T. S. J., Silvis, M. J. M., Cornel, J. H., Mosterd, A.

    Published in Netherlands heart journal (01-01-2022)
    “…Patients with coronary disease remain at high risk for future cardiovascular events, even with optimal risk factor modification, lipid-lowering drugs and…”
    Get full text
    Journal Article
  7. 7

    The Coronary Sinus Reducer; 5-year Dutch experience by Silvis, M. J. M., Dekker, M., Zivelonghi, C., Agostoni, P., Stella, P. R., Doevendans, P. A., de Kleijn, D. P. V., van Kuijk, J. P., Leenders, G. E., Timmers, L.

    Published in Netherlands heart journal (01-04-2021)
    “…Background Refractory angina is a growing and major health-care problem affecting millions of patients with coronary artery disease worldwide. The Coronary…”
    Get full text
    Journal Article
  8. 8

    Experimental parameters and infarct size in closed chest pig LAD ischemia reperfusion models; lessons learned by Silvis, Max J M, van Hout, Gerardus P J, Fiolet, Aernoud T L, Dekker, Mirthe, Bosch, Lena, van Nieuwburg, Martijn M J, Visser, Joyce, Jansen, Marlijn S, Timmers, Leo, de Kleijn, Dominique P V

    Published in BMC cardiovascular disorders (12-04-2021)
    “…Preclinical models that resemble the clinical setting as closely as possible are essential in translating promising therapies for the treatment of acute…”
    Get full text
    Journal Article
  9. 9

    Immunomodulation of the NLRP3 Inflammasome in Atherosclerosis, Coronary Artery Disease, and Acute Myocardial Infarction by Silvis, Max J. M., Demkes, Evelyne J., Fiolet, Aernoud T. L., Dekker, Mirthe, Bosch, Lena, van Hout, Gerardus P. J., Timmers, Leo, de Kleijn, Dominique P. V.

    “…Cardiovascular disease (CVD) remains the leading cause of mortality and morbidity worldwide. Atherosclerosis is responsible for the majority of cardiovascular…”
    Get full text
    Journal Article
  10. 10
  11. 11

    NLRP3-Inflammasome Inhibition with IZD334 Does Not Reduce Cardiac Damage in a Pig Model of Myocardial Infarction by Silvis, Max J M, Demkes, Evelyne J, Timmers, Leo, Arslan, Fatih, de Jager, Saskia C A, Sluijter, Joost P G, Mosterd, Arend, de Kleijn, Dominique P V, Bosch, Lena, van Hout, Gerardus P J

    Published in Biomedicines (28-11-2022)
    “…NLRP3-inflammasome-mediated signaling is thought to significantly contribute to the extent of myocardial damage after myocardial infarction (MI). The purpose…”
    Get full text
    Journal Article
  12. 12

    Extracellular Vesicles in Diagnosing Chronic Coronary Syndromes the Bumpy Road to Clinical Implementation by Dekker, Mirthe, Waissi, Farahnaz, Timmerman, Nathalie, Silvis, Max J M, Timmers, Leo, de Kleijn, Dominique P V

    “…Coronary artery disease (CAD), comprising both acute coronary syndromes (ACS) and chronic coronary syndromes (CCS), remains one of the most important killers…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Staphylococcus lugdunensis infective endocarditis with perforation of the sinus of Valsalva: a case report by Silvis, M J M, van den Heuvel, F M A, van Garsse, L, Nijveldt, R

    Published in European heart journal : case reports (01-04-2023)
    “…Abstract Background Staphylococcus lugdunensis endocarditis is a rare but fulminant disease. Case summary A 74-year-old female with a history of asymptomatic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    End-of-trial inflammatory biomarkers, lipid levels, creatine kinase and markers of renal and liver function in the LoDoCo2 trial by Van Broekhoven, A, Mohammadnia, N, Silvis, M J M, Los, J, Fiolet, A T L, Opstal, T S J, Mosterd, A, Eikelboom, J W, Nidorf, S M, Bax, W A, Tijssen, J G P, De Kleijn, D P V, Thompson, P L, El Messaoudi, S, Cornel, J H

    Published in European heart journal (03-10-2022)
    “…Abstract Background The Low-Dose Colchicine 2 (LoDoCo2) trial demonstrated that colchicine reduced major cardiovascular events in patients with chronic…”
    Get full text
    Journal Article
  20. 20

    Staphylococcus lugdunensis infective endocarditis with perforation of the sinus of Valsalva: a case report by Silvis, M J M, van den Heuvel, F M A, van Garsse, L, Nijveldt, R

    Published in European heart journal. Case reports (01-04-2023)
    “…BackgroundStaphylococcus lugdunensis endocarditis is a rare but fulminant disease. Case summaryA 74-year-old female with a history of asymptomatic severe…”
    Get full text
    Report